CompletedNCT00181844
Lamotrigine for mania in young people with bipolarity
About this title
Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar Disorder
Read the official source — NCT00181844Researchers studied lamotrigine to find out how it affected manic symptoms in young people with bipolarity type II during a manic episode.
Medication studyAges 6–17United States
Understand this study
What did researchers investigate?
Researchers studied lamotrigine to find out how it affected manic symptoms in young people with bipolarity type II during a manic episode.
Who was this study for?
Listed age limits: 6 years to 17 years.
What did participation involve?
The study group receives lamotrigine as a study medication.
- Listed locations
- CambridgeSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJanuary 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 51
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 6 Years to 17 Years
- Official registry ID
- NCT00181844
- Official title
Show the full official title
A Pilot Open Study of the Safety and Effectiveness of Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cambridge
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers studied lamotrigine to find out how it affected manic symptoms in young people with bipolarity type II during a manic episode.
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including lamotrigine.
Who was this study for?
Listed age limits: 6 years to 17 years.
